ØU Biotech nr.5/2017 - Ny analyse af bla. Nordic Nanovector
Acarix, ADDvice Group, ALK-Abelló, AstraZeneca, Bavarian Nordic, BioGaia, Camurus, CELLINK, Cyxone, Diamyd Medical, Dignitana, Episurf Medical, Hofseth Biocare, Immune Pharmaceuticals, Immunovia, Immunicum, InDex Pharmaceuticals, Karolinska Development, Medivir, Nordic Nanovector, Nuevolution, Oncopeptides, Onxeo, Recipharm, Revenio Group og Saniona.